Literature DB >> 9376183

Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures.

F Blot1, M Guiguet, G Nitenberg, B Leclercq, B Gachot, B Escudier.   

Abstract

The admission of neutropenic patients to an intensive care unit (ICU) is still controversial, especially if mechanical ventilation is required. To avoid useless stays in ICU, the evaluation of the respective role of the underlying malignancy and acute organ failures might be useful for better definition of the categories of patients who could benefit from aggressive ICU support. For this purpose, we carried out a retrospective study of the charts of 107 consecutive neutropenic patients admitted to an ICU in a comprehensive cancer centre over a four-year period. The following characteristics were recorded within 24 h of admission: patient data, characteristics of neutropenia and the underlying malignancy, the type and number of organ system failures (OSFs) and simplified acute physiological scores (SAPS and SAPS II). The impact of each variable on outcome in the ICU was studied by univariate and multivariate (logistic regression) analysis. 59 patients died in the ICU (mortality rate: 55%). Patients with a haematological malignancy (n = 57, 53%) were more likely to experience respiratory failure, an underlying malignancy deemed rapidly fatal, and to have longer lasting neutropenia than patients with a solid tumour (n = 50, 47%). However, the mortality rate did not differ in the two groups (haematological malignancy 61% versus solid tumour 48%, p = 0.16). Respiratory and cardiovascular organ failure (p < 0.001 for both) correlated with mortality in the ICU. In the multiple logistic regression model, only the number of organ system failures and respiratory failure remained predictive of ICU mortality. In conclusion, the characteristics of the underlying malignancy are not relevant when deciding whether or not neutropenic patients should be admitted to an ICU. The main risk factors for death in an ICU are the number of organ failures on admission, and among them the presence of respiratory failure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9376183     DOI: 10.1016/s0959-8049(97)00042-7

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  23 in total

Review 1.  Diagnostic strategy in cancer patients with acute respiratory failure.

Authors:  Elie Azoulay; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2006-04-29       Impact factor: 17.440

2.  [Mortality of hematology-oncology patients with neutropenia in intensivecare].

Authors:  I Suárez; B Böll; A Shimabukuro-Vornhagen; G Michels; M von Bergwelt-Baildon; M Kochanek
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-05-21       Impact factor: 0.840

3.  Changes in severity and organ failure scores as prognostic factors in onco-hematological malignancy patients admitted to the ICU.

Authors:  B Lamia; M-F Hellot; C Girault; F Tamion; F Dachraoui; P Lenain; G Bonmarchand
Journal:  Intensive Care Med       Date:  2006-08-01       Impact factor: 17.440

4.  Indwelling time and risk of infection of dialysis catheters in critically ill cancer patients.

Authors:  Abbas Harb; Georges Estphan; Gérard Nitenberg; Elisabeth Chachaty; Bruno Raynard; François Blot
Journal:  Intensive Care Med       Date:  2005-04-16       Impact factor: 17.440

5.  Patients with haematological malignancies requiring invasive mechanical ventilation: differences between survivors and non-survivors in intensive care unit.

Authors:  Radoslaw Owczuk; Magdalena A Wujtewicz; Wioletta Sawicka; Anna Wadrzyk; Maria Wujtewicz
Journal:  Support Care Cancer       Date:  2004-12-10       Impact factor: 3.603

6.  Documented and clinically suspected bacterial infection precipitating intensive care unit admission in patients with hematological malignancies: impact on outcome.

Authors:  Dominique D Benoit; Pieter O Depuydt; Renaat A Peleman; Fritz C Offner; Koenraad H Vandewoude; Dirk P Vogelaers; Stijn I Blot; Lucien A Noens; Francis A Colardyn; Johan M Decruyenaere
Journal:  Intensive Care Med       Date:  2005-03-22       Impact factor: 17.440

7.  CCC meets ICU: redefining the role of critical care of cancer patients.

Authors:  Michael von Bergwelt-Baildon; Michael J Hallek; Alexander A Shimabukuro-Vornhagen; Matthias Kochanek
Journal:  BMC Cancer       Date:  2010-11-08       Impact factor: 4.430

8.  Six-month prognosis of patients with lung cancer admitted to the intensive care unit.

Authors:  Sébastien Roques; Antoine Parrot; Armelle Lavole; Pierre-Yves Ancel; Valérie Gounant; Michel Djibre; Muriel Fartoukh
Journal:  Intensive Care Med       Date:  2009-09-19       Impact factor: 17.440

9.  Improved survival of critically ill cancer patients with septic shock.

Authors:  Jérôme Larché; Elie Azoulay; Fabienne Fieux; Laurent Mesnard; Delphine Moreau; Guillaume Thiery; Michaël Darmon; Jean-Roger Le Gall; Benoît Schlemmer
Journal:  Intensive Care Med       Date:  2003-09-12       Impact factor: 17.440

10.  Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database.

Authors:  Peter A Hampshire; Catherine A Welch; Lawrence A McCrossan; Katharine Francis; David A Harrison
Journal:  Crit Care       Date:  2009-08-25       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.